New Study Shows Actonel Almost Halves The Risk Of Hip Fractures Compared To Alendronate

Fri, 24 Nov 2006 05:00 PM EST

... Data published from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel® (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. [click link for full article] ...